Global Chronic Kidney Disease Drugs Market Size, Status and Forecast 2022
- QYR1051567
- 91 Pages
- March 2017
- Medical Devices
This report studies the global Chronic Kidney Disease Drugs market, analyzes and researches the Chronic Kidney Disease Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Keryx Biopharmaceuticals, Inc
Kissei Pharmaceutical Co., Ltd
AbbVie
GlaxoSmithKline
Sanofi
F. Hoffmann-La Roche Ltd
Pfizer
AstraZeneca
Amgen
Teva Pharmaceutical Industries
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Chronic Kidney Disease Drugs can be split into
ACE Inhibitors
Calcium Channel Blockers
Beta Blockers
Others
Market segment by Application, Chronic Kidney Disease Drugs can be split into
Hospitals
Specialty Clinics
Global Chronic Kidney Disease Drugs Market Size, Status and Forecast 2022
1 Industry Overview of Chronic Kidney Disease Drugs
1.1 Chronic Kidney Disease Drugs Market Overview
1.1.1 Chronic Kidney Disease Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Global Chronic Kidney Disease Drugs Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Chronic Kidney Disease Drugs Market by Type
1.3.1 ACE Inhibitors
1.3.2 Calcium Channel Blockers
1.3.3 Beta Blockers
1.3.4 Others
1.4 Chronic Kidney Disease Drugs Market by End Users/Application
1.4.1 Hospitals
1.4.2 Specialty Clinics
2 Global Chronic Kidney Disease Drugs Competition Analysis by Players
2.1 Chronic Kidney Disease Drugs Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 Keryx Biopharmaceuticals, Inc
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Kissei Pharmaceutical Co., Ltd
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 AbbVie
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 GlaxoSmithKline
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 Sanofi
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 F. Hoffmann-La Roche Ltd
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 Pfizer
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 AstraZeneca
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 Amgen
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Teva Pharmaceutical Industries
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Chronic Kidney Disease Drugs Revenue (Value) (2012-2017)
3.10.5 Recent Developments
4 Global Chronic Kidney Disease Drugs Market Size by Type and Application (2012-2017)
4.1 Global Chronic Kidney Disease Drugs Market Size by Type (2012-2017)
4.2 Global Chronic Kidney Disease Drugs Market Size by Application (2012-2017)
4.3 Potential Application of Chronic Kidney Disease Drugs in Future
4.4 Top Consumer/End Users of Chronic Kidney Disease Drugs
5 United States Chronic Kidney Disease Drugs Development Status and Outlook
5.1 United States Chronic Kidney Disease Drugs Market Size (2012-2017)
5.2 United States Chronic Kidney Disease Drugs Market Size and Market Share by Players (2016 and 2017)
6 EU Chronic Kidney Disease Drugs Development Status and Outlook
6.1 EU Chronic Kidney Disease Drugs Market Size (2012-2017)
6.2 EU Chronic Kidney Disease Drugs Market Size and Market Share by Players (2016 and 2017)
7 Japan Chronic Kidney Disease Drugs Development Status and Outlook
7.1 Japan Chronic Kidney Disease Drugs Market Size (2012-2017)
7.2 Japan Chronic Kidney Disease Drugs Market Size and Market Share by Players (2016 and 2017)
8 China Chronic Kidney Disease Drugs Development Status and Outlook
8.1 China Chronic Kidney Disease Drugs Market Size (2012-2017)
8.2 China Chronic Kidney Disease Drugs Market Size and Market Share by Players (2016 and 2017)
9 India Chronic Kidney Disease Drugs Development Status and Outlook
9.1 India Chronic Kidney Disease Drugs Market Size (2012-2017)
9.2 India Chronic Kidney Disease Drugs Market Size and Market Share by Players (2016 and 2017)
10 Southeast Asia Chronic Kidney Disease Drugs Development Status and Outlook
10.1 Southeast Asia Chronic Kidney Disease Drugs Market Size (2012-2017)
10.2 Southeast Asia Chronic Kidney Disease Drugs Market Size and Market Share by Players (2016 and 2017)
11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Chronic Kidney Disease Drugs Market Size (Value) by Regions (2017-2022)
11.1.1 United States Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.2 EU Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.3 Japan Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.4 China Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.5 India Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
11.2 Global Chronic Kidney Disease Drugs Market Size (Value) by Type (2017-2022)
11.3 Global Chronic Kidney Disease Drugs Market Size by Application (2017-2022)
12 Chronic Kidney Disease Drugs Market Dynamics
12.1 Chronic Kidney Disease Drugs Market Opportunities
12.2 Chronic Kidney Disease Drugs Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Chronic Kidney Disease Drugs Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Chronic Kidney Disease Drugs Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source
Figure Chronic Kidney Disease Drugs Product Scope
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) (2012-2017)
Table Global Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Kidney Disease Drugs Market Share by Regions in 2016
Figure United States Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure EU Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Japan Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure China Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure India Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Southeast Asia Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Figure Global Chronic Kidney Disease Drugs Market Share by Type in 2016
Figure ACE Inhibitors Market Size (Million USD) and Growth Rate (2012-2017)
Figure Calcium Channel Blockers Market Size (Million USD) and Growth Rate (2012-2017)
Figure Beta Blockers Market Size (Million USD) and Growth Rate (2012-2017)
Figure Others Market Size (Million USD) and Growth Rate (2012-2017)
Figure Global Chronic Kidney Disease Drugs Market Share by Application in 2016
Figure Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate in Hospitals (2012-2017)
Figure Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate in Specialty Clinics (2012-2017)
Figure Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate in Applications 3 (2012-2017)
Table Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2016 and 2017)
Figure Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Table Keryx Biopharmaceuticals, Inc Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of Keryx Biopharmaceuticals, Inc (2012-2017)
Figure Keryx Biopharmaceuticals, Inc Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table Kissei Pharmaceutical Co., Ltd Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of Kissei Pharmaceutical Co., Ltd (2012-2017)
Figure Kissei Pharmaceutical Co., Ltd Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table AbbVie Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of AbbVie (2012-2017)
Figure AbbVie Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table GlaxoSmithKline Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of GlaxoSmithKline (2012-2017)
Figure GlaxoSmithKline Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table Sanofi Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of Sanofi (2012-2017)
Figure Sanofi Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table F. Hoffmann-La Roche Ltd Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of F. Hoffmann-La Roche Ltd (2012-2017)
Figure F. Hoffmann-La Roche Ltd Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table Pfizer Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of Pfizer (2012-2017)
Figure Pfizer Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table AstraZeneca Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of AstraZeneca (2012-2017)
Figure AstraZeneca Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table Amgen Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of Amgen (2012-2017)
Figure Amgen Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table Teva Pharmaceutical Industries Basic Information List
Table Chronic Kidney Disease Drugs Business Revenue of Teva Pharmaceutical Industries (2012-2017)
Figure Teva Pharmaceutical Industries Chronic Kidney Disease Drugs Business Revenue Market Share in 2016
Table Global Chronic Kidney Disease Drugs Market Size (Million USD) by Type (2012-2017)
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2012
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2013
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2014
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2015
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2016
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2017
Table Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application (2012-2017)
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2012
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2013
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2014
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2015
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2016
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2017
Table Top Consumer/End Users of Chronic Kidney Disease Drugs
Figure United States Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table United States Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure United States Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure United States Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Figure EU Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table EU Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure EU Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure EU Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Figure Japan Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Japan Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure Japan Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure Japan Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Figure China Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table China Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure China Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure China Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Figure India Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table India Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure India Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure India Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Figure Southeast Asia Chronic Kidney Disease Drugs Market Size (Million USD) and Growth Rate by Regions (2012-2017)
Table Southeast Asia Chronic Kidney Disease Drugs Market Size (Million USD) by Players (2012-2017)
Figure Southeast Asia Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2016
Figure Southeast Asia Chronic Kidney Disease Drugs Market Size (Million USD) Share by Players in 2017
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) (Value) by Regions (2017-2022)
Table Global Chronic Kidney Disease Drugs Market Size (Million USD) by Regions (2017-2022)
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Regions in 2017
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Regions in 2022
Figure United States Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
Figure EU Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
Figure Japan Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
Figure China Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
Figure India Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
Figure Southeast Asia Chronic Kidney Disease Drugs Revenue and Growth Rate (2017-2022)
Table Global Chronic Kidney Disease Drugs Market Size (Million USD) by Type (2017-2022)
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2017
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) Share by Type in 2022
Table Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application (2017-2022)
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2017
Figure Global Chronic Kidney Disease Drugs Market Size (Million USD) by Application in 2022
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
